Multiple Myeloma

Showing NaN - NaN of 99

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fluoroquinolone Resistance Prevalence Study

Recruiting
  • Multiple Myeloma
    • Washington, District of Columbia
    • +1 more
    Apr 10, 2023

    Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

    Recruiting
    • Multiple Myeloma
    • BB2121
    • +2 more
    • Birmingham, Alabama
    • +33 more
    Jan 26, 2023

    Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Birmingham, Alabama
    • +60 more
    Jan 24, 2023

    Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)

    Active, not recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +87 more
    Jan 17, 2023

    Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +26 more
    Jan 17, 2023

    Multiple Myeloma Trial in Worldwide (Daratumumab, Pomalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +198 more
    Jan 17, 2023

    Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Daratumumab IV
    • +3 more
    • Birmingham, Alabama
    • +211 more
    Jan 17, 2023

    Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Scottsdale, Arizona
    • +5 more
    Jan 12, 2023

    Multiple Myeloma Trial in Worldwide (CC-220, Dexamethasone, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +126 more
    Jan 10, 2023

    Multiple Myeloma Trial in Hackensack (Thalidomide+Melphalan +Bortezomib+stem cell transplant)

    Completed
    • Multiple Myeloma
    • Thalidomide+Melphalan +Bortezomib+stem cell transplant
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Dec 16, 2022

    Multiple Myeloma Trial in United States (Isatuximab, Carfilzomib, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Isatuximab
    • +2 more
    • San Francisco, California
    • +3 more
    Dec 24, 2022

    Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

    Active, not recruiting
    • Multiple Myeloma
    • Auto Stem Cell Transplant
    • Hackensack, New Jersey
      John Theurer Cancer Center @ Hackensack University Medical Cente
    Dec 23, 2022

    Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • bb2121
    • +8 more
    • Birmingham, Alabama
    • +59 more
    Dec 13, 2022

    Multiple Myeloma Trial in Worldwide (GEN3014 (HexaBody®-CD38))

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Atlanta, Georgia
    • +19 more
    Dec 12, 2022

    Multiple Myeloma, DLBCL, Glioblastoma Multiforme Trial in Worldwide (CC-223)

    Completed
    • Multiple Myeloma
    • +6 more
    • Los Angeles, California
    • +15 more
    Dec 9, 2022

    Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • +3 more
    • Birmingham, Alabama
    • +25 more
    Dec 9, 2022

    Multiple Myeloma Trial in Leicester (CC-92480, Tazemetostat, BMS-986158)

    Recruiting
    • Multiple Myeloma
    • Birmingham, Alabama
    • +9 more
    Oct 24, 2022

    Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

    Active, not recruiting
    • Multiple Myeloma
    • Elranatamab (PF-06863135)
    • Beverly Hills, California
    • +75 more
    Oct 4, 2022

    Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +139 more
    Sep 9, 2022

    Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

    Recruiting
    • Multiple Myeloma
    • Cilta-cel
    • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
    • Duarte, California
    • +23 more
    Aug 1, 2022

    Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

    Terminated
    • Multiple Myeloma
    • Atlanta, Georgia
    • +8 more
    Jul 28, 2022

    Multiple Myeloma Trial in Greece, Korea, Republic of, United States (Belantamab mafodotin)

    Recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Tucson, Arizona
    • +21 more
    Jul 20, 2022

    Multiple Myeloma Trial in Hackensack (Bortezomib)

    Terminated
    • Multiple Myeloma
    • Hackensack, New Jersey
      The Cancer Center at Hackensack University Medical Center
    Jun 24, 2022

    Multiple Myeloma Trial in Worldwide (bb2121)

    Active, not recruiting
    • Multiple Myeloma
    • bb2121
    • San Francisco, California
    • +47 more
    Jul 18, 2022

    Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    • Multiple Myeloma
    • bb2121
    • +3 more
    • Scottsdale, Arizona
    • +19 more
    Jul 7, 2022